# Study to Evaluate the Pharmacokinetics, Safety, and QTc Effect of AG-348 in Healthy Subjects of Japanese Origin and Non-Asian Origin

> **NCT03250598** · PHASE1 · COMPLETED · sponsor: **Agios Pharmaceuticals, Inc.** · enrollment: 60 (actual)

## Conditions studied

- Healthy
- Japanese
- Non-Asian

## Interventions

- **DRUG:** AG-348
- **DRUG:** AG-348
- **DRUG:** AG-348

## Key facts

- **NCT ID:** NCT03250598
- **Lead sponsor:** Agios Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-09
- **Primary completion:** 2017-10-02
- **Final completion:** 2017-10-09
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03250598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03250598, "Study to Evaluate the Pharmacokinetics, Safety, and QTc Effect of AG-348 in Healthy Subjects of Japanese Origin and Non-Asian Origin". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03250598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*